Skip to main content
. 2018 Apr 16;68(4):306–313. doi: 10.1007/s13224-018-1119-3

Table 1.

Demographic data of the study population

Dienogest Leuprolide acetate Test of significance p value
Age 29.52 ± 3.32 29.77 ± 3.09 t = − 0.601 0.548
Weight 67.55 ± 6.65 67.19 ± 6.97 t = 0.406 0.685
BMI 25.03 ± 1.45 24.84 ± 1.47 t = 0.991 0.323
VAS of pelvic pain 59.27 ± 11.02 58.73 ± 11.01 t = 0.343 0.732
VAS of back pain 45.91 ± 3.33 46.68 ± 3.29 t = − 1.358 0.177
VAS of dyspareunia 36.53 ± 3.87 34.98 ± 4.96 t = 1.859 0.066
Stage of endometriosis
I 30 (24.8%) 27 (22.3%) X2 = 0.42 0.93
II 36 (29.8%) 39 (32.2%)
III 32 (26.4%) 34 (28.1%)
IV 23 (19.0%) 21 (17.4%)